Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | GRB2 | P62993 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17352470 | 0.91 | OPRM1 (0.46) | OPRM1F2XIAP | |
| SCHEMBL29366371 | 0.91 | OPRM1 (0.46) | OPRM1F2XIAP | |
| SCHEMBL29374739 | 0.90 | OPRM1 (0.45) | OPRM1OPRD1OPRK1GRB2SLC6A2 | |
| SCHEMBL31065472 | 0.90 | OPRM1 (0.45) | OPRM1OPRD1OPRK1GRB2SLC6A2 | |
| SCHEMBL29377214 | 0.90 | DPP4 (0.50) | OPRM1F2XIAP | |
| SCHEMBL30286923 | 0.89 | OPRM1 (0.55) | OPRM1GRB2F2 | |
| SCHEMBL17352458 | 0.88 | OPRM1 (0.43) | OPRM1SLC6A2F2XIAP | |
| SCHEMBL31316132 | 0.87 | OPRM1 (0.54) | OPRM1F2XIAP | |
| SCHEMBL31134542 | 0.87 | CAPN1 (0.46) | OPRM1OPRD1OPRK1SLC6A2XIAP | |
| SCHEMBL29355564 | 0.87 | GRB2 (0.47) | OPRM1GRB2F2XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230304025-A1 | M13 BACTERIOPHAGE WITH A HIGH CYSTEINE CONTENT AND GENETICALLY ENGINEERABLE HYDROGELS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-09-28 | — | — | US | disclosed |
| WO-2022020380-A1 | M13 BACTERIOPHAGE WITH A HIGH CYSTEINE CONTENT AND GENETICALLY ENGINEERABLE HYDROGELS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-01-27 | — | — | WO | disclosed |